XDemics Enter Distribution Agreement with VWR, Part of Avantor, to Expand Access to Expansify™ High-Density Cultureware Products
SAN RAFAEL, Calif., (Jan. 16, 2026) -- XDemics Corporation, a Caltech spinout developing advanced cell production technologies, has signed a sales, distribution, and marketing agreement with VWR, part of Avantor (NYSE: AVTR), one of the world’s largest and most trusted laboratory supply networks. This agreement significantly expands availability of XDemics’ Expansify™ line of high-density cultureware designed for cell culture applications and intensified bioproduction in a laboratory setting.
Under the agreement, customers worldwide will be able to order the Expansify™ product portfolio directly through VWR’s industry-leading digital platform and extensive field sales organization. VWR will actively promote and distribute Expansify products to academic institutions, biopharmaceutical companies, CDMOs, cell and gene therapy developers, and government research facilities.
“This agreement with VWR marks a pivotal moment for XDemics,” said Christopher Thanos, CEO of XDemics. “By combining Expansify’s proven performance advantages with VWR’s unmatched reach and customer trust, we are accelerating adoption of our next-generation cell culture solutions that help scientists achieve more consistent, scalable, and reproducible results."
Key benefits of the partnership include:
- Seamless ordering and faster delivery through VWR’s global distribution infrastructure
- Enhanced product visibility via placement across VWR’s digital catalogs, e-commerce platform, and field sales initiatives
- Expanded technical and customer support for complex, high-density cell culture workflows
The collaboration positions Expansify as a solution within the Avantor ecosystem, enabling more researchers and process development teams to overcome traditional limitations in cell growth, viability, and scalability.
The Expansify product line is now immediately available through VWR in North America.
About XDemics
XDemics Corporation is developing the High-Density Cell Respiration (HDCR™) platform to overcome the oxygen delivery and shear stress limitations of conventional cell culture systems, enabling direct control of pericellular oxygen at any setpoint and achieving up to 100-fold higher cell densities with improved product potency and quality. The company's Expansify™ respiring cultureware and Profusion™ bioreactor products (under development) utilize HDCR™ to enable predictable, linear scaleup from 96-well plates to large bioreactors, supporting workflows from early discovery to commercial production of T cell, stem cell, and viral-based therapies. XDemics 40-0002 rev A.0 holds an exclusive license to a broad IP portfolio from Caltech and City of Hope, complemented by significant IP generated in-house. The company is headquartered in San Rafael, California.
Expansify™ cultureware is currently for research use only.
How to reach us:
- For more information, please visit www.xdemics.com
- General inquiries, please email: info@xdemics.com
- Technical support or questions, please email: support@xdemics.com